Skip to content

Clinical trials

Observational Myocardial Infarction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Observational Clear all

766 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
200112
20026
200316
200412
200511
200619
200727
200811
200919
201035
201130
201227
201327
201438
201536
201626
201724
201834
201935
202043
202140
202236
202330
202430
202533
202630

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed421
Unknown status161
Recruiting78
Active, not recruiting33
Not yet recruiting32
Terminated20
Withdrawn16
Enrolling by invitation5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)40
University College, London16
Assiut University12
University of Edinburgh10
University of Washington9
Brigham and Women's Hospital8
Mayo Clinic8
AstraZeneca7
London School of Hygiene and Tropical Medicine7
French Cardiology Society6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction766
Cardiovascular Diseases137
Stroke123
Acute Coronary Syndrome111
Coronary Artery Disease109
Heart Diseases91
Coronary Disease87
Heart Failure83
Myocardial Ischemia69
ST Elevation Myocardial Infarction54

Trials

Showing 51 to 75 of 766. Each trial links to its page on Pharma Observatory.

666 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.